![Eric Burak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Burak
Technik-/Wissenschafts-/F&E-Leiter bei
FUSN PHAR
Profil
Eric Burak is currently Chief Technology Officer at Fusion Pharmaceuticals, Inc. since 2021, with employment at the company starting in 2017.
Former positions include Director-Drug Metabolism & Pharmacokinetics at Guilford Pharmaceuticals, Inc., Vice President-Advanced Preclinical Development at Melinta Subsidiary Corp., Vice President-Development at Theracos, Inc. from 2011 to 2012, and Chief Scientific Officer at Centre For Probe Development & Commercialization from 2012 to 2017.
Education includes undergraduate studies at Drexel University and a doctorate from Temple University (Pennsylvania).
Aktive Positionen von Eric Burak
| Unternehmen | Position | Beginn |
|---|---|---|
| FUSN PHAR | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2017 |
Ehemalige bekannte Positionen von Eric Burak
| Unternehmen | Position | Ende |
|---|---|---|
Centre For Probe Development & Commercialization
 Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2017 |
Theracos, Inc.
 Theracos, Inc. BiotechnologyHealth Technology Develops novel therapeutics for diseases | Corporate Officer/Principal | 01.10.2012 |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Corporate Officer/Principal | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Corporate Officer/Principal | - |
Ausbildung von Eric Burak
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
34
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Theracos, Inc.
Theracos, Inc. BiotechnologyHealth Technology Develops novel therapeutics for diseases | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
